Literature DB >> 7846202

Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal.

P Sachdev1.   

Abstract

This paper argues for consistency in the conceptualization and definition of drug-induced akathisia (DIA), something found lacking in published research reports. It suggests the adoption of a common set of provisional categories with operationally defined diagnostic criteria. The categories proposed are acute, tardive, withdrawal and chronic DIA, with overlap of chronic DIA with the other three. The prerequisites for diagnosis are drug exposure, the presence of characteristic clinical features and the exclusion of non-drug causes. The frequency of the clinical features, and their nature, determine the level of certainty. A decision regarding severity is made independently of diagnostic certainty. Some ways of testing the usefulness and validity of these definitions are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 7846202     DOI: 10.1007/bf02245462

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  The Hillside Akathisia Scale: a new rating instrument for neuroleptic-induced akathisia.

Authors:  W W Fleischhacker; K J Bergmann; R Perovich; L K Pestreich; M Borenstein; J A Lieberman; J M Kane
Journal:  Psychopharmacol Bull       Date:  1989

Review 2.  Neuroleptic-induced akathisia: a review.

Authors:  L A Adler; B Angrist; S Reiter; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  A rating scale for drug-induced akathisia.

Authors:  T R Barnes
Journal:  Br J Psychiatry       Date:  1989-05       Impact factor: 9.319

4.  Diagnosing diagnoses. Receiver operating characteristic methods and psychiatry.

Authors:  J K Hsiao; J J Bartko; W Z Potter
Journal:  Arch Gen Psychiatry       Date:  1989-07

5.  Unilateral "akathisia" in a patient with AIDS and a toxoplasmosis subthalamic abscess.

Authors:  E Carrazana; E Rossitch; J Martinez
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

Review 6.  The restless legs syndrome.

Authors:  W R Gibb; A J Lees
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

7.  The clinical phenomenon of akathisia.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

8.  Efficacy of propranolol in neuroleptic-induced akathesia.

Authors:  L Adler; B Angrist; E Peselow; J Corwin; J Rotrosen
Journal:  J Clin Psychopharmacol       Date:  1985-06       Impact factor: 3.153

9.  Akathisia variants and tardive dyskinesia.

Authors:  T R Barnes; W M Braude
Journal:  Arch Gen Psychiatry       Date:  1985-09

10.  Tardive akathisia: an analysis of clinical features and response to open therapeutic trials.

Authors:  R E Burke; U J Kang; J Jankovic; L G Miller; S Fahn
Journal:  Mov Disord       Date:  1989       Impact factor: 10.338

View more
  3 in total

Review 1.  Managing antipsychotic-induced acute and chronic akathisia.

Authors:  C H Miller; W W Fleischhacker
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

Review 2.  Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Authors:  M R Caligiuri; D V Jeste; J P Lacro
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

3.  The Assessment and Treatment of Antipsychotic-Induced Akathisia.

Authors:  Tamara Pringsheim; David Gardner; Donald Addington; Davide Martino; Francesca Morgante; Lucia Ricciardi; Norman Poole; Gary Remington; Mark Edwards; Alan Carson; Thomas R E Barnes
Journal:  Can J Psychiatry       Date:  2018-04-23       Impact factor: 4.356

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.